Skip to main content
Clinical Trials/NCT04142840
NCT04142840
Unknown
Early Phase 1

Comparing the Efficacy of Dexmedetomidine and Propofol in the Treatment of Emergence Agitation Occurring in Adults After General Anesthesia: A Randomised Control Trial DP-TEA Trial

RenJi Hospital1 site in 1 country120 target enrollmentNovember 1, 2019

Overview

Phase
Early Phase 1
Intervention
Dexmedetomidine
Conditions
Emergence Agitation
Sponsor
RenJi Hospital
Enrollment
120
Locations
1
Primary Endpoint
The recurrence rate of emergence agitation assessed by the Riker Sedation-Agitation Scale after the treatment of each group.
Last Updated
6 years ago

Overview

Brief Summary

  1. This clinical research aims to compare the effects of dexmedetomidine and propofol on the treatment of emergence agitation in adult patients after general anesthesia.
  2. Half of participants will receive dexmedetomidine while the other half will receive propofol when emergence agitation happens.

Detailed Description

As a common problem observed in pediatric patients after sevoflurane anesthesia, emergence agitations are investigated mainly in children.For adults,previous studies were almost about the efficacy of premedication on preventing emergence agitation. Once emergence agitation happens, there is still no guidelines established to recommend the medication usage in the post-anaesthesia care unit.So high-quality prospective clinical studies are required to provide evidence for emergence agitation treatment. Dexmedetomidine and propofol are both widely used in general anesthesia and can be acquired easily.When emergence agitation occurs,both injections are common choices in daily clinical administration on emergence agitation.To the investigator's knowledge ,propofol with a very quick onset is superior for anesthesia goals, but is without analgesia effects.While dexmedetomidine can produce sedation,analgesia,anxiolysis.So the investigators propose the hypothesis here that dexmedetomidine is prior to propofol on the treatment of emergence agitation in adults patients after general anesthesia.Therefore this research is undertaken to verify the hypothesis.

Registry
clinicaltrials.gov
Start Date
November 1, 2019
End Date
August 30, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 18-65 years old after general anesthesia
  • with informed consent provided.

Exclusion Criteria

  • age younger than 18 years or older than 65 years;
  • American Society of Anesthesiologists classification ≥Ⅲ;
  • preoperative lung dysfunction(including pneumonia,atelectasis,adult respiratory distress syndrome,acute lung injury and so on);
  • preoperative heart dysfunction(including sever cardiac coronary disease,unstable angina,LVEF≤30%,sick sinus syndrome,bradycardia:heart rate≤50bpm,second or third degree A-V block);
  • history of mental disease;
  • no informed consent provided;
  • uncontrolled hypertension(baseline blood pressure:SBP≥160mmHg or DBP≥110mmHg);
  • enrolled in other researches within 90 days;
  • allergic to intervening medicine.
  • BMI less than 18 or more than 30 kg/m2.

Arms & Interventions

Dexmedetomidine Group

General anesthesia will be maintained by sevoflurane and remifentanil. End-tidal carbon dioxide will be controlled between 35 mmHg to 40 mmHg.Mean blood pressure(MAP) will be administrated between 80% and 120% of the baseline.Heart rate is going to be maintained between 50-100 beats per minute. In consultation with the surgeons and 5 minutes prior to the departure of the operating room,all the anesthesia agents are discontinued and the patient will be transferred to the post-anaesthesia care unit.And reversal agents are given to antagonize the residual muscular relaxant.Once emergence agitation occurs,the patient assigned to the dexmedetomidine group will be infused with a single dose of 0.7ug/kg dexmedetomidine.

Intervention: Dexmedetomidine

Propofol Group

General anesthesia will be maintained by sevoflurane and remifentanil. End-tidal carbon dioxide will be controlled between 35 mmHg to 40 mmHg.Mean blood pressure(MAP) will be administrated between 80% and 120% of the baseline.Heart rate is going to be maintained between 50-100 beats per minute. In consultation with the surgeons and 5 minutes prior to the departure of the operating room,all the anesthesia agents are discontinued and the patient will be transferred to the post-anaesthesia care unit.And reversal agents are given to antagonize the residual muscular relaxant.Once emergence agitation occurs,the patient assigned to the propofol group will be infused with a single dose of 0.5mg/kg propofol.

Intervention: Propofol

Outcomes

Primary Outcomes

The recurrence rate of emergence agitation assessed by the Riker Sedation-Agitation Scale after the treatment of each group.

Time Frame: 1 day

1. The Riker Sedation-Agitation Scale is raging from a maximum value of 7 to a minimum value of 1.Lower scores mean a better outcome. 2. A Riker Sedation-Agitation scale score of 5 or more than 5 will be considered as emergence agitation.

Secondary Outcomes

  • Riker Sedation-Agitation Scale scores before and after intervention;(1 day)
  • Heart rate before and after intervention;(1 day)
  • The consumption of sufentanil in the post-anaesthesia care unit;(1 day)
  • Nausea and vomiting scores when leaving the post-anesthesia care unit.(1 day)
  • Duration in the post-anaesthesia care unit(1 day)
  • Recovering quality: recovery scale(24 hours after surgery.)
  • Mean blood pressure before and after intervention;(1 day)

Study Sites (1)

Loading locations...

Similar Trials